Redefining Polycystic Ovary Syndrome As Polyendocrine Metabolic Ovarian Syndrome: Implications For Diagnosis, Pathophysiology And Clinical Management

The document discusses the proposal to redefine Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better capture its complex pathophysiology and systemic metabolic effects. The current focus on ovarian morphology in PCOS diagnosis often overlooks significant metabolic dysfunctions, such as insulin resistance and cardiovascular risks, leading to delayed and inappropriate treatment. The review emphasizes the need for a comprehensive approach to management, including personalized nutrition, lifestyle changes, hormonal therapy, psychological support, and multidisciplinary care, to improve long-term health outcomes for women affected by this condition.